General Information of the Compound
Compound ID |
CP0010315
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(+)-boldine
Show/Hide
|
||||||||||||||||||
Synonyms |
(+)-Boldine
(S)-(+)-Boldine
(S)-Boldine
1,10-Dimethoxy-2,9-dihydroxyaporphine
1,10-Dimethoxy-6a-alpha-aporphine-2,9-diol
476-70-0
4H-Dibenzo(de,g)quinoline-2,9-diol, 5,6,6a,7-tetrahydro-1,10-dimethoxy-6-methyl-, (6aS)-
4H-Dibenzo(de,g)quinoline-2,9-diol, 5,6,6a,7-tetrahydro-1,10-dimethoxy-6-methyl-, (S)-
8I91GE2769
BOLDINE
BRN 0094036
Boldin
Boldine
Boldine chloroform
CHEBI:3148
CHEMBL388342
EINECS 207-509-9
LZJRNLRASBVRRX-ZDUSSCGKSA-N
NSC 65689
UNII-8I91GE2769
Uniboldina
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C19H21NO4
|
||||||||||||||||||
Molecular Weight |
327.38
|
||||||||||||||||||
Canonical SMILES |
COc1cc-2c(C[C@@H]3N(C)CCc4cc(O)c(OC)c-2c34)cc1O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C19H21NO4/c1-20-5-4-10-7-15(22)19(24-3)18-12-9-16(23-2)14(21)8-11(12)6-13(20)17(10)18/h7-9,13,21-22H,4-6H2,1-3H3/t13-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
LZJRNLRASBVRRX-ZDUSSCGKSA-N
|
||||||||||||||||||
CAS |
476-70-0
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound